Employees Retirement System Of Texas Galapagos Nv Transaction History

Employees Retirement System Of Texas

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$122.47 - $213.56 $732,738 - $1.28 Million	-5,983 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$146.12 - $215.82 $2.19 Million - $3.24 Million	-15,000 Reduced 71.49%	5,983 $1.24 Million
Q3 2019 Nov 12, 2019	SELL	$130.44 - $187.64 $784,857 - $1.13 Million	-6,017 Reduced 22.29%	20,983 $3.2 Million
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $89,610 - $117,780	1,000 Added 3.85%	27,000 $3.18 Million
Q3 2018 Nov 13, 2018	SELL	$90.63 - $120.22 $4.08 Million - $5.41 Million	-45,000 Reduced 63.38%	26,000 $2.92 Million
Q2 2018 Aug 10, 2018	BUY	$88.4 - $105.34 $1.33 Million - $1.58 Million	15,000 Added 26.79%	71,000 $6.55 Million
Q1 2018 May 11, 2018	BUY	$94.51 - $120.23 $189,020 - $240,460	2,000 Added 3.7%	56,000 $5.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	54,000	54,000 $4.13 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.